Pregnancy up-regulated, nonubiquitous CaM kinase

Chemistry: molecular biology and microbiology – Vector – per se

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C536S023100, C536S023400, C536S023500, C435S325000, C530S350000

Reexamination Certificate

active

07041495

ABSTRACT:
This invention relates generally to a novel CaM multi-functional protein kinase, which has been named Pregnancy Up-Regulated, Nonubiquitous CaM Kinase (PNCK), and to the nucleotide sequence encoding it. The kinase is temporally expressed during postnatal mammary development in a spatially heterogeneous manner in certain subsets of cells, and overexpressed in a subset of primary breast cancers. The invention further relates to an analysis of a correlation between carcinogenesis and postnatal development, particularly mammary development, especially associated with parity; as well as to methods of using the kinase, or gene encoding it, as markers, prognostic tools, screening tools and therapies, in vitro and in vivo that are based upon that correlation.

REFERENCES:
Gardner HP, et al. Genomics, Jan. 15, 2000; 63 (2): 279-88.
Kiley SC, et al. J Mammary Gland Biol Neoplasia. Apr. 1996; 1 (2): 177-87.
USPTO search report “us-10-032-254a-2.rge”, pp. 1 and 2 of the “Alignments” (result 1).
Skolnick J, et al. Trends Biotechnol Jan. 2000; 18 (1): 34-9.
Lazar E, et al. Mol Cell Biol Mar. 1988; 8 (3): 1247-52.
Burgess WH, et al. J Cell Biol Nov. 1990; 111 (5 Pt 1): 2129-38.
Bowie JU, et al. Science Mar. 16, 1990; 247 (4948): 1306-10.
Houdebine LM. J Biotechnol. May 31, 1994; 34 (3): 269-87.
Verma IM, et al. Nature. Sep. 18, 1997; 389 (6648): 239-42.
Patterson AP. Memorandum (Jan. 14, 2003); pp. 3.
Pandha HS, et al. Cur Opin Invest Drugs. 2000; 1 (1): 122-34.
Amalfitano A, et al. Cur Gene Ther. 2002; 2: 111-33.
USPTO search report “us-10-032-254a-1.rge”, pp. 1 and 2 of the “Alignments” (result 1).
Shirai Y, et al. Jpn J Pharmacol. Dec. 1998; 78 (4) :411-7.
Lehninger et al. (Principles of Biochemistry, 2nd Ed., Worth Publishers: New York, 1993, pp. 984-995).
Bendig MM. Genet. Eng. 1988; (7): 91-127.
Aasheim, H. C., Terstappen, L. W., and Logtenberg, T. “Regulated expression of the Eph-related receptor tyrosine kinase Hek11 in early human B lymphopoiesis.”Blood90: 3613-3122 (1997).
Adams, R. H., Wilkinson, G. A., Weiss, C., Diella, F., Gale, N. W., Deutsch, U., Risau, W., and Klein, R. “Roles of ephrinB ligands and EphB receptors in cardiovascular development: De-marcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis.”Genes Dev. 13: 295-306 (1999).
Adnane, J., Gaudray, P., Dionne, C. A., Crumley, G., Jaye, M., Schlessinger, J., Jeanteur, P., Birnbaum, D., and Theillet, C. “BEK and FLG, two receptors to members of the FGF family, are amplified in subsets of human breast cancers.”Oncogene6: 659-663 (1991).
Andres, A.-C., Zuercher, G., Djonov, V., Flueck, M., and Ziemiecki, A. “Protein tyrosine kinase expression during the estrous cycle and carcinogenesis of the mammary gland.”Int. J. Cancer63: 288-296 (1995).
Baitinger, C., Alderton, J., Poenie, M., Schulman, H., and Steinhardt, R. A. “Multi-functional Ca 21 /calmodulin-dependent protein kinase is necessary for nuclear envelope breakdown.”J. Cell Biol. 111: 1763-1773 (1990).
Bergemann, A. D., Zhang, L., Chiang, M. K., Brambilla, R., Klein, R., and Flanagan, J. G. “Ephrin-B3, a ligand for the receptor EphB3, expressed at the midline of the developing neural tube.”Oncogene16: 471-480 (1998).
Birchmeier, C., Sonnenberg, E., Weidner, K. M., and Walter, B. “Tyrosine kinase receptors in the control of epithelial growth and morphogenesis during development.”BioEssays15: 185-190 (1993).
Bolen, J. B. “Nonreceptor tyrosine protein kinases.”Oncogene8: 2025-2031 (1993).
Bolen, J. B., Rowley, R. B., Spana, C., and Tsygankov, A. Y. “The Src family of tyrosine protein kinases in hemopoietic signal transduction.”FASEB J. 6: 3403-3409 (1992).
Braun, A. P., and Schulman, H. “The multifunctional calcium/calmodulin-dependent protein kinase: From form to function.”Annu. Rev. Physiol. 57: 417-445 (1995).
Brinkley, P. M., Class, K., Bolen, J. B., and Penhallow, R. C. “Structure and developmental regulation of the murine ctk gene.”Gene163: 179-184 (1995).
Cance, W. G., Craven, R. J., Weiner, T. M., and Liu, E. T. “Novel protein kinases expressed in human breast cancer.”Int. J. Cancer54: 571-577 (1993).
Cardiff, R. D., and Muller, W. J. “Transgenic mouse models of mammary tumorigenesis.”Cancer Surv. 16:97-113 (1993).
Cardiff, R. D., Sinn, E., Muller, W., and Leder, P. “Transgenic onogene mice. Tumor phenotype predicts genotype.”Am. J. Pathol. 139: 495-501 (1991).
Cawley, K. C., Akita, C. G., Angelos, K. L., and Walsh, D. A. “Characterization of the gene for rat phosphorylase kinase catalytic subunit.”J. Biol. Chem. 268: 1194-1200 (1993).
Centanni, J. M., de Miguel, M., Gopalan, G., Gilbert, D. J., Copeland, N. G., Jenkins, N. A., and Donovan, P.J. “Interleukin-1 receptor-associated kinase gene Illrak maps to the mouse X chro-mosome.”Mamm. Genome9: 340-341 (1998).
Cho, R. J., Campbell, M. J., Winzeler, E. A., Steinmetz, L., Conway, a., Wodicka, L., Wolfsberg, T. G., Gabrielian, A. E., Landsman, D., Lockhart, D. J., and Davis, R. W. “A genome-wide transcriptional analysis of the mitotic cell cycle.”Mol. Cell2: 65-73 (1998).
Chodosh, L. A., D'Cruz, C. M., Gardner, H. P., Ha, S. I., Marquis, S. T., Rajan, J. V., Stairs, D. B., Wang, J. Y., and Wang, M. “Mammary gland development, reproductive history, and breast cancer risk.”Cancer Res. 59: 1765-1771S (1999).
Chodosh, L. A., Gardner, H. P., Rajan, J. V., Stairs, D. B., Marquis, S. T., and Leder, P. A. “Protein kinase expression during murine mammary development.”Dev. Biol. 219: 259-276, (2000).
Copeland, N. G., and Jenkins, N. A. “Development and applications of a molecular genetic linkage map of the mouse genome.”Trends Genet. 7: 113-118 (1991).
Dickson, R. B., Salomon, D. S., and Lippman, M. E. “Tyrosine kinase receptor-nuclear protooncogene interactions in breast cancer.”Cancer Treatment Res. 61: 249-273 (1992).
Dymecki, S. M., Niederhuber, J. E., and Desiderio, S. V. “Specific expression of a tyrosine kinase gene, blk, in B lymphoid cells.”Science247: 332-336 (1990).
Elson, A., and Leder, P. “Protein-tyrosine phosphatase epsilon. An isoform specifically expressed in mouse mammary tumors initiated by v-Ha-ras or neu.”J. Biol. Chem. 270: 26116-26122 (1995).
Fantl, W. J., Johnson, D. E., and Williams, L. T. “Signalling by receptor tyrosine kinases.”Annu. Rev. Biochem. 62: 453-481 (1993).
Ferrari, S., Manfredini, R., Tagliafico, E., Grande, A., Barbieri, D., Balestri, R., Pizzanelli, M., Zucchini, P., Citro, G., Zupi, G., et al. “Antiapoptotic effect of c-fes protooncogene during granu-locytic differentiation.”Leukemia8: S91-94 (1994).
Fox, G. M., Holst, P. L., Chute, H. T., Lindberg, R. A., Janssen, A. M., Basu, R., and Welcher, A. A. “cDNA cloning and tissue distribution of five human EPH-like receptor protein-tyrosine kinases.”Oncogene10: 897-905 (1995).
Fukunaga, K., and Miyamoto, E. “Current studies on a working model of CaM kinase II in hippocampal long-term potentiation and memory.”Jpn. J. Pharmacol. 79: 7-15 (1999).
Ganju, P., Walls, E., Brennan, J., and Reith, A. D. “Cloning and developmental expression of Nsk2, a novel receptor tyrosine kinase implicated in skeletal myogenesis.”Oncogene11: 281-290 (1995).
Gardner, H. P., Belka, G. K., Wertheim, G. B. W., Hartman, J. L., Ha, S. I., Marquis, S. T., and Chodosh, L. A. “Developmental role of the SNF-1-related kinase Hunk in pregnancy-induced changes in the mammary gland.”Development(Camb.) in press (2000).
Gardner, H. P., Wertheim, G. B. W., Ha, S. I., Copeland, N. G., Gilbert, D. J., Jenkins, N. A., Marquis, S. T., and Chodosh, L. A. “Cloning and characterization of Hunk, a novel mammalian SNF1-related protein kinase.”Genomics63: 46-59 (2000).
Goldberg, J., Nairn,

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Pregnancy up-regulated, nonubiquitous CaM kinase does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pregnancy up-regulated, nonubiquitous CaM kinase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pregnancy up-regulated, nonubiquitous CaM kinase will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3563873

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.